USD 3.4 billion
Report ID:
SQMIG35I2087 |
Region:
Global |
Published Date: October, 2024
Pages:
219
|Tables:
90
|Figures:
75
Global Narcolepsy Drugs Market size was valued at around USD 3.4 billion in 2022 and is expected to rise from USD 3.7 billion in 2023 to reach a value of USD 7 billion by 2031, at a CAGR of 9.5% over the forecast period (2024–2031).
The market is primarily driven by the aging population, and their vulnerability to various chronic and acute diseases that require medical care.The rise in narcoleptic diseases, changing lifestyles, and the rise in stress levels, which cause narcolepsy disorder are also projected to aid in market expansion during the forecast period. Furthermore, the narcolepsy therapeutics market is projected to witness significant growth in the coming years owing to increase in research efforts, rise in healthcare expenditure,, and the presence of enhanced medical infrastructure.
The symptoms of central hypersomnia can be controlled by circadian delay, more sleep, and teleworking. Due to the low consumption of narcolepsy treatments and the public's desire for better sleep circumstances, the narcolepsy drugs market is projected to witness significant growth in the coming years.
On the other hand, high expenses and a lack of knowledge about the availability of treatment for narcolepsy may limit market expansion in the future. In addition to this, high treatment and diagnostic costs as well as an unfavourable reimbursement environment are the factors that will restrain market expansion. The narcolepsy treatment market would face challenges throughout the forecast period due to decreased operating revenue opportunities for targeted therapy research and development by various pharmaceuticals.
US Narcolepsy Drugs Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 3.4 billion
Largest Segment
Hospitals
Fastest Growth
Tricyclic Antidepressants
Growth Rate
9.60% CAGR
To get more reports on the above market click here to Buy The Report
Global Narcolepsy Drugs Market is segmented by Disease Type, Therapeutics Type, and region. Based on Disease Type, the market is segmented into Daytime Extreme Sleepiness, Cataplexia, and Other Disease Type. Based on Therapeutics Type, the market is segmented into Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Other Therapeutic Type. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Narcolepsy Drugs Market Analysis by Therapeutics:
The market is segmented into central nervous system stimulants, sodium oxybate, tricyclic antidepressants, selective serotonin reuptake inhibitors, and others based on therapeutic kind. Due to its great efficacy in treating cataplexy and excessive daytime drowsiness, the existence of advantageous reimbursement policies, and growing public knowledge of diagnosis and related therapies, sodium oxybate is anticipated to register the highest CAGR throughout the projection period.
Narcolepsy Drugs Market Analysis by End User:
Due to the increased use of polysomnography, numerous sleep latency tests, and other diagnostic tests to diagnose narcolepsy patients, the hospitals segment held the largest share in the market. During a polysomnographic study, the patient's brain waves, blood oxygen levels, heart rate, breathing, and eye and leg movements are all recorded. If a patient has previously been diagnosed with a sleep problem, polysomnography can be utilized to help modify the treatment plan in addition to narcolepsy diagnostics. Additionally, it is typically carried out at sleep centres or hospital units that deal with sleep disorders.
To get detailed analysis on other segments, Request For Free Sample Report
The market in North America is expected to continue dominating the market and derive benefits from factors such as higher healthcare expenditure, presence of strong global players, and favourable reimbursement policy structure. The high prevalence rate of narcolepsy in the United States and Canada are further expected to help attract significant revenues for this region. A strong clinical pipeline also helps to sustain the local narcolepsy medication industry. A sizable portion of the population still has at least one sleep-related condition, which is expected to maintain the market's potential for growth higher in North America.
Due to the expansion of healthcare infrastructure in nations such as India, the Asia Pacific region is predicted to experience moderate growth in the worldwide market in the future. A further factor that may support market expansion in the Asia Pacific region is the strengthening of healthcare reimbursement regulations in developing nations.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Narcolepsy Drugs Market Drivers
Increasing Awareness of Narcolepsy Treatment
Rise in The Number of Narcolepsy Patient
Narcolepsy Drugs Market Restraint
Lack of Awareness
Request Free Customization of this report to help us to meet your business objectives.
The competitive landscape of the narcolepsy treatment market gives information by competitor. Company overview, financials, revenue generated, market potential, investments in R&D, new market initiatives, global presence, production facilities, company strengths and weaknesses, product launch, clinical trial pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve are among the details provided. The aforementioned data points are limited to the companies' market research focus on narcolepsy treatment.
Narcolepsy Drugs Market Top Player's Company Profiles
Narcolepsy Drugs Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to SkyQuest, the global market for pharmaceuticals includes the market for narcolepsy medications. The degrees of growth of the narcolepsy medications market over the projected period will be determined by external factors impacting the parent market growth potential in the ensuing years, which have been extensively discussed in our research report.
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to a detailed SkyQuest exclusive matrix.
Report Metric | Details |
---|---|
Market size value in 2022 | USD 3.4 billion |
Market size value in 2031 | USD 7 billion |
Growth Rate | 9.5% |
Base year | 2023 |
Forecast period | 2024–2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Narcolepsy Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Narcolepsy Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Narcolepsy Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Narcolepsy Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35I2087